Breath analysis in critically ill patients: Potential and limitations

Expert Review of Molecular Diagnostics

Volumn 4, Issue 5, 2004, Pages 619-629

  Schubert, Jochen K ^a   Miekisch, Wolfram ^a   Geiger, Klaus ^b   Nöldge Schomburg, Gabriele F E ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acetone; Allograft rejection; Breath test; Ethane; Isoprene; Lipid peroxidation; Oxidative stress; Pentane; Sepsis; SIRS

Indexed keywords

ARTIFICIAL VENTILATION; BREATH ANALYSIS; CLINICAL RESEARCH; CRITICAL ILLNESS; HUMAN; INFLAMMATION; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PATIENT MONITORING; REVIEW; TRANSPLANTATION;

BIOLOGICAL MARKERS; BREATH TESTS; CHOLESTEROL; CRITICAL ILLNESS; EQUIPMENT DESIGN; GRAFT REJECTION; HUMANS; HYDROCARBONS; KIDNEY FAILURE; LIPID PEROXIDATION; LIVER DISEASES; MODELS, THEORETICAL; RESPIRATION, ARTIFICIAL; VOLATILIZATION;

EID: 4544345635     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.4.5.619     Document Type: Review

References (100)

1. Phillips M, Herrera J, Krishan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B. Biomed. Sci. Appl. 729, 75-88 (1999).
2. Gustafsson LE. Exhaled nitric oxide as a marker in asthma. Eur. Respir. J. 26(Suppl.), 49-52 (1998). Basic information on nitric oxide (NO) as a marker of airway inflammation.
3. Yates DH. Role of exhaled nitric oxide in asthma. Immunol. Cell. Biol. 79(2), 178-190 (2001).
4. Chapman JT, Choi AM. Exhaled monoxides as a pulmonary function test: use of exhaled nitric oxide and carbon monoxide. Clin. Chest. Med. 22, 817-836 (2001).
5. Kharitonov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 7, 1-32 (2002). Review on breath biomarkers including NO, carbon monoxide (CO) and breath condensate.
6. Riery CA, Cohen G, Lieberman M. Ethane evolution: a new index of Lipid peroxidation. Science 183(121), 208-210 (1974).
7. Frankel EN. Volatile lipid oxidation products. Prog. Lipid Res. 22, 1-33 (1982). One of the first publications describing formation and role of volatile peroxidation markers.
8. Van-Rij AM, Wade CR. In vivo lipid peroxidation in man as measured by the respiratory excretion of ethane, pentane, and other low-molecular-weight hydrocarbons. Anal. Biochem. 150, 1-7 (1985).
9. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during acute myocardial infarction. Lancet 337, 933-935 (1991).
10. Miller ER III, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 96, 1097-1101 (1997).
11. Kazui M, Andreoni KA, Norris EJ et al. Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. Free Radic. Biol. Med. 13, 509-515 (1992). Pioneering work on ethane as a marker of ischemia/reperfusion injury.
12. Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17, 127-160 (1994). Comprehensive review on breath analysis up until 1994.
13. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am. J. Gastroentenrol. 98, 348-353 (2003).
14. Risby TH, Sehnert SS. Clinical application of breath biomarkers of oxidative stress status. Free Radic. Biol. Med. 27, 1182-1192(1999). Comprehensive review on markers of oxidative stress/injury.
15. Lebovitz HE. Diabetic ketoacidosis. Lancet 345, 767-772 (1995).
16. Nelson N, Lagesson V, Nosratabadi AR, Ludvigsson J, Tagesson C. Exhaled isoprene and acetone in newborn infants and in children with diabetes mellitus. Ped. Res. 44, 363-337 (1998).
17. Stone BG, Besse TJ, Duane WC, Evans CD, DeMaster EG. Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men. Lipids 28, 705-708 (1993). Basic information on physiologic meaning of isoprene.
18. Chen S, Zieve L, Mahadevan V. Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine. J. Lab. Clin. Med. 75(4), 628-635 (1970).
19. Scislowski PW, Pickard K. The regulation of transaminative flux of methionine in rat liver mitochondria. Arch. Biochem. Biophys. 314(2), 412-416 (1994).
20. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. N. Engl. J. Med. 297, 132-135 (1977).
21. Davies S, Spanel P, Smith D. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. Kidney Int. 52, 223-228 (1997). Interesting new application of mass spectrometry technology.
22. Marczin N, Wright G, Yacoub MH. Determinants of exhaled nitric oxide: influence of ventilation and pulmonary blood flow. In: Lung Biology in Health and Disease. Disease Markers in Exhaled Breath. Marczin N, Kharitonov S (Eds), Marcel Dekker, NY, USA, 91-113 (2003).
23. 2-controlled sampling of alveolar gas in mechanically ventilated patients. J. Appl. Physiol. 90, 486-492 (2001). Systematic study on breath sampling methods.
24. Schubert JK, Esteban-Loos I, Geiger K, Guttmann J. In vivo evaluation of a new method for chemical analysis of volatile components in the respiratory gas of mechanically ventilated patients. Technol. Health Care 7, 29-37 (1999).
25. Pleil JD, Lindstrom AB. Measurement of volatile organic compounds in exhaled breath as collected in evacuated electropolished canisters. J. Chromatogr. B 665, 271-279 (1995). Pioneering work concerning environmental exposition and its analysis.
26. Phillips M, Greenberg J. Ion-trap detection of volatile organic compounds in alveolar breath. Clin. Chem. 38, 60-65 (1992). Basic information on volatile substances found in breath.
27. Mueller W, Schubert J, Benzing A, Geiger K. Method for analysis of exhaled air by microwave energy desorption coupled with gas chromatography-flame ionization detection-mass spectrometry. J. Chromatogr. B. Biomed. Sci. Appl. 716, 27-38 (1998). Basic information on preconcentration techniques.
28. Grote C, Pawliszyn J. Solid-phase microextraction for the analysis of human breath. Anal. Chem. 69, 587-596 (1997). Description of a novel preconcentration method.
29. Miekisch W, Schubert JK, Vagts DA, Geiger K. Analysis of volatile disease markers in blood. Clin. Chem. 47, 1053-1060 (2001). Application of solid-phase microextraction for headspace analysis in blood.
30. Knutson MD, Viteri FE. Concentrating breath samples using liquid nitrogen: a reliable method for the simultaneous determination of ethane and pentane. Anal. Biochem. 242, 129-135 (1996).
31. Tangerman A, Meuwese-Arends MT, van Tongeren JH. New methods for the release of volatile sulfur compounds from human serum: its determination by Tenax trapping and gas chromatography and its application in liver diseases. Lab. Clin. Med. 106(2), 175-182 (1985).
32. Risby TH. Volatile organic compounds as markers in normal and desaesed states. In: Disease Markers in Exhaled Breath. Marczin N, Yacoub MH (Eds), IOS Press, Amsterdam, The Netherlands, 113-124 (2002). Comprehensive review on volatile breath markers.
33. Lärstad M, Loh C, Ljungkvist G, Olin AC, Toren K. Determination of ethane, pentane and isoprene in exhaled air using a multi-bed adsorbent and end-cut gas-solid chromatography. Analyst 127, 1440-1445 (2002).
34. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free. Radic. Biol. Med. 28, 880-886 (2000).
35. Spanel P, Davies S, Smith D. Quantification of breath isoprene using the selected ion flow tube mass spectrometric analytical method. Rapid Commun. Mass. Spectrom. 13, 1733-1738 (1999). Interesting novel mass spectrometry application.
36. McGrath LT, Patrick R, Mallon P et al. Breath isoprene during acute respiratory exacerbation in cystic fibrosis. Europ. Resp. J. 16, 1065-1069 (2000).
37. Lord H, Yu Y, Segal A, Pawliszyn J. Breath analysis and monitoring by membrane extraction with sorbent interface. Anal. Chem. 74, 5650-5657 (2002). Technical progress in preconcentration and sampling.
38. Marchetti N, Felinger A, Pasti L, Pietrogrande MC, Dondi F. Decoding two-dimensional complex multicomponent separations by autocovariance function. Anal. Chem. 76(11), 3055-3068 (2004).
39. Bueno PA Jr, Seeley JV. Flow-switching device for comprehensive two-dimensional gas chromatography. J. Chromatogr. A 1027(1-2), 3-10 (2004).
40. Meyer MJ, Schiefler GM, Mocker EK, Brodersen JJ, Swenson OF, Borgerding AJ. Selective detection of volatile aromatic compounds using a compact laser ionization detector with fast gas chromatography. Anal. Chem. 76(6), 1702-1707 (2004). New technical solutions.
41. Whalley LK, Lewis AC, McQuaid JB et al. Two high-speed, portable GC systems designed for the measurement of non-methane hydrocarbons and PAN: results from the Jungfraujoch High Altitude Observatory. J. Environ. Monit. 6(3), 234-241 (2004).
42. Dahnke H, Kleine D, Hering P, Mürtz M. Real-time monitoring of ethane in human breath using mid-infrared cavity leak-out spectroscopy. J. Appl. Phys. B 72, 971-975 (2001). Pioneering work on laser spectroscopy for ethane analysis.
43. Spanel P, Smith D. Selected ion flow tube: a technique for quantitative trace gas analysis of air and breath. Med. Biol. Eng. Comput 34, 409-419 (1996).
44. Steiner WE, Glowers BH, English WA, Hill HH Jr. Atmospheric pressure matrix-assisted laser desorption/ionization with analysis by ion mobility time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18(8), 882-888 (2004).
45. Mohamed EI, Bruno E, Linder R et al. A novel method for diagnosing chronic rhinosinusitis based on an electronic nose. An. Otorrinolaringol. Ibero. Am. 30, 447-457 (2003).
46. Di Natale C, Macagnano A, Maninelli E et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron. 18, 1209-1218 (2003).
47. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocrinol. Metab. 88(3), 1082-1088 (2003).
48. Kobayashi T, Seguchi H. Novel insight into current models of NADPH oxidase regulation, assembly and localization in human polymorphonuclear leukocytes. Histol. Histopathol. 14, 1295-1308 (1999).
49. Gredilla R, Phaneuf S, Selman C, Kendaiah S, Leeuwenburgh C, Barja G. Short-term caloric restriction and sites of oxygen radical generation in kidney and skeletal muscle mitochondria. Ann. NY Acad. Sci. 1019, 333-342 (2004).
50. Nohl H, Gille L, Kozlov A, Staniek K. Are mitochondria a spontaneous and permanent source of reactive oxygen species? Redox. Rep. 8(3), 135-141 (2003).
51. Metidiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: relevance to Cyto(neuro)toxic events and neurological disorders. An overview. Neurotox. Res. 1(3), 197-233 (2000).
52. Reilly PM, Schiller HJ, Bulkley GB. Pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am. Surg. 161, 488-503 (1991).
53. Sun K, Kiss E, Bedke J et al. Role of xanthine oxidoreductase in experimental acute renal-allograft rejection. Transplantation 77(11), 1683-1692 (2004).
54. Izumi M, McDonald MC, Sharpe MA, Chatterjee PK, Thiemermann C. Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 18(3), 230-235 (2002).
55. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic. Biol. Med. 28(6), 880-886 (2000).
56. Evans CD, List GR, Doley A, McConel DG, Hoffman RL. Pentane from thermal decomposition of lipoxidase-derived products. Lipids 2, 432-434 (1967).
57. Dumelin EE, Tappel AL. Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides. Lipids 12, 894-900 (1977).
58. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am. J. Gastroenterol. 98(2), 348-353 (2003).
59. Scholpp J, Schubert JK, Miekisch W, Geiger K. Breath markers and soluble lipid peroxidation markers in critically ill patients. Clin. Chem. Lab. Med. 40(6), 587-594 (2002). Clinical application of breath analysis.
60. Kohlmuller D, Kochen W. Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Anal. Biochem. 210(2), 268-276 (1993).
61. Phillips M, Cataneo RN, Greenberg J, Grodman R, Gunawardena R, Naidu A. Effect of oxygen on breath markers of oxidative stress. Eur. Respir. J. 21(1), 48-51 (2003).
62. Phillips M, Cataneo RN, Greenberg J, Gunawardena R, Rahbari-Oskoui F. Increased oxidative stress in younger as well as in older humans. Clin. Chim. Acta 328(1-2), 83-86 (2003).
63. Mitsui T, Kondo T. Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress. Clin. Chim. Acta 333, 91-94 (2003).
64. Kazui M, Andreoni KA, Williams GM et al. Visceral lipid peroxidation occurs at reperfusion after supraceliac aortic cross-clamping. J. Vasc. Surg. 19, 473-477 (1994).
65. Mendis S, Sobotka PA, Leja FL, Euler DE. Breath pentane and plasma lipid peroxides in ischemic heart disease Free Radic. Biol. Med. 19(5), 679-684 (1995).
66. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during acute myocardial infarction. Lancet 337, 933-935 (1991).
67. Andreoni KA, Kazui M, Cameron DE et al. Ethane: a marker of lipid peroxidation during cardiopulmonary bypass in humans. Free Radic. Biol. Med. 26, 439-444 (1999).
68. Sobotka PA, Gupta DK, Lansky DM, Costanzo MR, Zarling EJ. Breath pentane is a marker of acute cardiac allograft rejection. J. Heart Lung Transplant. 13, 224-229 (1994).
69. Van Gossum A, Kurian R, Whitwell J, Jeejeebhoy KN. Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E. Clin. Nutrition 7, 53 (1988).
70. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, Zarling EJ. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic. Biol. Med. 14(6), 643-647 (1993).
71. Miller ER, Appel LJ, Jiang L, Risby TH. The effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation 98, 2390-2395 (1998).
72. Smith D, Spanel P, Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. J. Appl. Physiol. 87(5), 1584-1588 (1999).
73. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 189(1-2), 41-54 (2003).
74. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am. J. Respir. Crit. Care Med. 162, 1450-1454 (2000).
75. Olopade CO, Zakkar M, Swedler WI, Rubinstein I. Exhaled pentane levels in acute asthma. Chest 111, 862-865 (1997).
76. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162, 369-373 (2000).
77. Olopade CO, Christen JA, Zakkar M et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111, 1500-1504 (1997).
78. Schubert JK, Müller WPE, Benzing A, Geiger K. Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med. 24, 415-421 (1998). Isoprene and acute respiratory distress syndrome.
79. Schubert JK, Miekisch W, Geiger K. Exhaled breath markers in ARDS. In: Lung Biology in Health and Disease, Disease Markers in Exhaled Breath. Marczin N, Kharitonov S (Eds), Marcel Dekker, NY, USA, 363-380 (2003).
80. Kharitonov SA, Chung FK, Evans DJ, O'Connor BJ, Barnes PJ. The elevated level of exhaled nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract. Am. J. Respir. Crit. Care. Med. 153, 1773-1780 (1996). Origin and source of exhaled NO.
81. Foster MW, Jiang L, Stetkiewicz PT, Risby TH. Breath isoprene: temporal changes in respiratory output after exposure to ozone. J. Appl. Physiol. 80, 706-710 (1996). Isoprene and oxidative injury in the lung.
82. Mendis S, Sobotka PA, Euler DE. Expired hydrocarbons in patients with acute myocardial infarction. Free Rad. Res. 23, 117-122 (1995).
83. Mauriello G, Moio L, Moschetti G, Piombino P, Addeo F, Coppola S. Characterization of lactic acid bacteria strains on the basis of neutral volatile compounds produced in whey. J. Appl. Microbiol. 90(6), 928-942 (2001).
84. Claeson AS, Levin JO, Blomquist G, Sunesson AL. Volatile metabolites from microorganisms grown on humid building materials and synthetic media. J. Environ. Monit. 4(5), 667-672 (2002).
85. Davis PL, Dal Cortivo LA, Maturo J. Endogenous isopropanol: forensic and biochemical implications. J. Anal. Toxicol. 8(5), 209-212 (1984).
86. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5), 1340-1347 (2000). Clinical application of breath analysis.
87. Scislowski PW, Pickard K. The regulation of transaminative flux of methionine in rat liver mitochondria. Arch. Biochem. Biophys. 314(2), 412-416 (1994).
88. Sehnert S, Jiang L, Burdick J, Risby T. Breath biomarkers for detection of human liver diseases: preliminary study. Biomarkers 7, 174-187 (2002).
89. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. J. Engl. J. Med. 297(3), 132-135 (1977).
90. Holt DW, Johnston A, Ramsey JD. Breath pentane and heart rejection. J. Heart Lung Transplant. 13(6), 1147-1148 (1994).
91. Studer SM, Orens JB, Rosas I et al. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J. Heart Lung Transplant. 20(11), 1158-1166 (2001). Promising clinical application of breath analysis.
92. Cope KA, Watson MT, Foster M, Sehnert SS, Risby TH. Effects of ventilation on the collection of exhaled breath in humans. J. Appl. Physiol. 96, 1371-1379 (2004). Important contribution concerning standardization of sampling methods.
93. West JB, Wagner PD. Pulmonary gas exchange. Am. J. Respir. Crit. Care Med. 157, S82-S87 (1998). Basic knowledge on pulmonary eras exchange.
94. Wagner, PD, Saltzman HA, West JB. Measurement of continuous distributions of ventilation-perfusion ratios: theory. J. Appl. Physiol. 36, 588-599 (1974). Description of multiple inert gas elimination technique.
95. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal. Biochem. 247, 272-278 (1997). Basics on breath analysis.
96. Lindstrom AB, Pleil J. A review of the USEPA's single breath canister (SBC) method for exhaled volatile organic biomarkers. Biomarkers 7(3), 189-208 (2002).
97. Wallace LA, Nelson WC, Pellizzari ED, Raymer JH. Uptake and decay of volatile organic compounds at environmental concentrations: application of a four compartment model to a chamber study of five human subjects. J. Expo. Anal. Environ. Epidemiol. 7(2), 141-163 (1997).
98. Phillips M, Cataneo RN, Cummin AR et al. Detection of lung cancer with volatile markers in the breath. Chest 123, 2115-2123 (2003). Interesting clinical application of breath analysis.
99. Dembinski R, Max M, Bensberg R, Bickenbach J, Kuhlen R, Rossaint R. High-frequency oscillatory ventilation in experimental lung injury: effects on gas exchange. Intensive Care Med. 28, 768-774 (2002).
100. Feihl F, Eckert P, Brimioulle S et al. Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 162, 209-215 (2000).